FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/06/088473 [Registered on: 10/06/2025] Trial Registered Prospectively
Last Modified On: 26/05/2025
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   use of Ocumap software 
Study Design  Other 
Public Title of Study   OcuMap – An Medical Decision Making tool for Intraocular Lens Selection 
Scientific Title of Study   OcuMap – A surgical Medical Decision-Making tool for Intraocular Lens Selection 
Trial Acronym  OcuMap 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sathyan Parthasarathi 
Designation  Director 
Affiliation  SATHYAN EYE CARE HOSPITAL & COIMBATORE GLAUCOMA FOUNDATION, 
Address  #77, Om Sakthi Nagar, Off Trichy Road, Sowripalayam Pirivu, Ramanathapuram, Coimbatore

Coimbatore
TAMIL NADU
641045
India 
Phone  9443259148  
Fax    
Email  dr.sathyan.p@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sathyan Parthasarathi 
Designation  Director 
Affiliation  SATHYAN EYE CARE HOSPITAL & COIMBATORE GLAUCOMA FOUNDATION, 
Address  #77, Om Sakthi Nagar, Off Trichy Road, Sowripalayam Pirivu, Ramanathapuram, Coimbatore

Coimbatore
TAMIL NADU
641045
India 
Phone  9443259148  
Fax    
Email  dr.sathyan.p@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Krishnakumar venkateswaran 
Designation  Engineer 
Affiliation  SATHYAN EYE CARE HOSPITAL & COIMBATORE GLAUCOMA FOUNDATION, 
Address  #77, Om Sakthi Nagar, Off Trichy Road, Sowripalayam Pirivu, Ramanathapuram, Coimbatore

Coimbatore
TAMIL NADU
641045
India 
Phone  6238726730  
Fax    
Email  krishna.venkat70@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  OCULOTIX Inc 
Address  801 Hermosa Way, Menlo Park, CA 94025  
Type of Sponsor  Other [software developers] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sathyan Parthasarathi   SATHYAN EYE CARE HOSPITAL & COIMBATORE GLAUCOMA FOUNDATION  #77, Om Sakthi Nagar, Off Trichy Road, Sowripalayam Pirivu, Ramanathapuram, Coimbatore - 641045,
Coimbatore
TAMIL NADU 
9443259148

dr.sathyan.p@gmail.com  
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Satyan Eye Care Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H259||Unspecified age-related cataract,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  All patients presenting for cataract surgery 
 
ExclusionCriteria 
Details  NONE 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
• Phase 1: Ocumap data feeding phase: Validation of Ocumap engine after training and validation using subset.
• Phase 2: Ocumap recommendations: Proportion of patients receiving IOL such as advanced monofocal, extended range of vision, Trifocal or Bifocal intraocular lens ; toric and non-toric versions of each lens included
 
Screening visit, Month 3 after implant 
 
Secondary Outcome  
Outcome  TimePoints 
• Surgeon time with patient during preoperative visit(s)
• Surgeon satisfaction with Ocumap, including
o Time to determine selection of intraocular lens
o Accuracy of Ocumap predictions
o Ocumap ease of use
o Utility of Ocumap and Ocumap lite for staff education
• Comparison of predicted and actual patient satisfaction with vision outcomes for distance vision, near vision, night vision, dysphotopsia and overall quality of vision
• Ease of use by the patient of patient reported outcome software application
 
Screening visit, Month 3 
 
Target Sample Size   Total Sample Size="15000"
Sample Size from India="15000" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   16/06/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

All data generated as a result of this assessment will be regarded as confidential, until appropriate analysis and review by  the Investigator(s) are completed. The results of the assessment may be published or presented by the Investigator(s) after the review and such that confidential or proprietary information is not disclosed.

Prior to publication or presentation, a copy of the final text should be forwarded to the Investigator(s) or its designee, for comment. Such comments shall aim to ensure the scientific integrity of the proposed publications and/or presentations and ensure that the data and material and activities receive fair, accurate, and reasonable presentation.

 
Close